Abstract
Functional characterization of pseudouridine (Ψ) in mammalian mRNA has been hampered by the lack of a quantitative method that maps Ψ in the whole transcriptome. We report bisulfite-induced deletion sequencing (BID-seq), which uses a bisulfite-mediated reaction to convert pseudouridine stoichiometrically into deletion upon reverse transcription without cytosine deamination. BID-seq enables detection of abundant Ψ sites with stoichiometry information in several human cell lines and 12 different mouse tissues using 10–20 ng input RNA. We uncover consensus sequences for Ψ in mammalian mRNA and assign different ‘writer’ proteins to individual Ψ deposition. Our results reveal a transcript stabilization role of Ψ sites installed by TRUB1 in human cancer cells. We also detect the presence of Ψ within stop codons of mammalian mRNA and confirm the role of Ψ in promoting stop codon readthrough in vivo. BID-seq will enable future investigations of the roles of Ψ in diverse biological processes.
Pseudouridine sites in mRNA are detected at base resolution and functionally investigated.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Zhang, Li-Sheng 1
; Sun, Hui-Lung 1 ; Pajdzik, Kinga 1 ; Yang, Lei 2 ; Ye, Chang 1
; Ju, Cheng-Wei 3 ; Liu, Shun 1 ; Wang, Yuru 1 ; Zheng, Zhong 1 ; Zhang, Linda 1 ; Harada, Bryan T. 1
; Dou, Xiaoyang 1 ; Irkliyenko, Iryna 4
; Feng, Xinran 5 ; Zhang, Wen 6
; Pan, Tao 6
; He, Chuan 7
1 The University of Chicago, Department of Chemistry, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); The University of Chicago, Howard Hughes Medical Institute, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
2 School of Medicine, Tongji University, First Maternity and Infant Hospital, Shanghai, China (GRID:grid.24516.34) (ISNI:0000000123704535)
3 The University of Chicago, Howard Hughes Medical Institute, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); The University of Chicago, Pritzker School of Molecular Engineering, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
4 The University of Chicago, Department of Chemistry, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
5 The University of Chicago, Howard Hughes Medical Institute, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); The University of Chicago, Department of Human Genetics, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
6 The University of Chicago, Department of Biochemistry and Molecular Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)
7 The University of Chicago, Department of Chemistry, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); The University of Chicago, Howard Hughes Medical Institute, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); The University of Chicago, Department of Biochemistry and Molecular Biology, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822); The University of Chicago, Institute for Biophysical Dynamics, Chicago, USA (GRID:grid.170205.1) (ISNI:0000 0004 1936 7822)





